Acute lymphoblastic leukaemia under 2 years.

Investigation of TEL/AML1 and BCR/ABL Fusion Genes in Patients Affected by Acute Lymphoblastic Leukaemia Using Interphase in situ Hybridization

Gene variants of CYP1A1 and CYP2D6 and the risk of childhood acute lymphoblastic leukaemia; outcome of a case control study from Kashmir, India

Studies on associations of various polymorphisms in xenobiotic metabolizing genes with different cancers including acute lymphoblastic leukaemia (ALL) are mixed and inconclusive. The current study analyzed the relationship between polymorphisms of phase I xenobiotic metabolizing enzymes, cytochromes P450 1A1 (CYP1A1) and CYP2D6 and childhood ALL in Kashmir, India. We recruited 200 confirmed ALL...

A Review on Acute Lymphoblastic Leukaemia

Introduction he leukaemias are malignant neoplasms of the haemopoietic stem cells. 1 acute leukaemia is the most common malignancy in children. 2 In the United States the incidence of ALL is roughly 6000 new cases per year (as of 2009), or approximately 1 in 50,000. 3 Acute lymphoblastic leukaemia makes up three quarters of all cases of leukaemia in children and 20% of all cases of leukaemia in...

Childhood Leukaemias

Acute lymphoblastic leukaemia (ALL) accounts for about 78% of all leukaemia diagnosed in children. ALL is the most common cancer in children [2] . Acute myeloid leukaemia (AML) is the next most common and accounts for 15% of childhood leukaemia. The incidence rates are highest in infants (under 1 year old) and show little variation from age 3 years onwards. Chronic myeloid leukaemia (CML) accou...

Acute lymphoblastic leukaemia.

Acute lymphoblastic leukaemia, a malignant disorder of lymphoid progenitor cells, affects both children and adults, with peak prevalence between the ages of 2 and 5 years. Steady progress in development of effective treatments has led to a cure rate of more than 80% in children, creating opportunities for innovative approaches that would preserve past gains in leukaemia-free survival while redu...